Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

被引：106
作者：
van Assen, S. [1 ]
Elkayam, O. [2 ,3 ,4 ]
Agmon-Levin, N. [5 ]
Cervera, R. [6 ]
Doran, M. F. [7 ]
Dougados, M. [8 ]
Emery, P. [9 ]
Geborek, P. [10 ]
Ioannidis, J. P. A. [11 ,12 ,13 ,14 ]
Jayne, D. R. W. [15 ]
Kallenberg, C. G. M. [16 ]
Mueller-Ladner, U. [17 ]
Shoenfeld, Y. [4 ,5 ]
Stojanovich, L. [18 ]
Valesini, G. [19 ]
Wulffraat, N. M. [20 ]
Bijl, M. [16 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Infect Dis, NL-9700 RB Groningen, Netherlands
[2] Med Ctr, Dept Internal Med F, Tel Aviv, Israel
[3] Med Ctr, Dept Rheumatol, Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[5] Chaim Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[6] Hosp Clin Barcelona, Dept Autoimmune Dis, Barcelona, Catalonia, Spain
[7] St James Hosp, Dept Rheumatol, Dublin, Ireland
[8] Hosp Cochin, Dept Rheumatol, Paris, France
[9] Univ Leeds, Sect Musculoskeletal Dis, Leeds Inst Mol Med, Musculoskeletal Biomed Res Unit,Leeds Teaching Ho, Leeds, W Yorkshire, England
[10] Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden
[11] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[12] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece
[13] Tufts Univ, Sch Med, Boston, MA 02111 USA
[14] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[15] Addenbrookes Hosp, Renal Unit, Cambridge, England
[16] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9700 RB Groningen, Netherlands
[17] Univ Giessen, Dept Rheumatol & Clin Immunol, Bad Nauheim, Germany
[18] Univ Belgrade, Univ Med Ctr, Dept Sci Res, Belgrade 11001, Serbia
[19] Univ Roma La Sapienza, Dept Med, Rome, Italy
[20] Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands
来源：
AUTOIMMUNITY REVIEWS | 2011年 / 10卷 / 06期
关键词：
PNEUMOCOCCAL POLYSACCHARIDE VACCINE; MYCOBACTERIUM-TUBERCULOSIS INFECTION; SQUAMOUS INTRAEPITHELIAL LESIONS; LUPUS-ERYTHEMATOSUS PATIENTS; INFLUENZA VACCINATION; HERPES-ZOSTER; ANTIBODY-RESPONSE; RISK-FACTORS; HEPATITIS-B; CLINICAL CHARACTERISTICS;
D O I：
10.1016/j.autrev.2010.12.003
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Objectives: To present the systematic literature review (SLR), which formed the basis for the European League Against Rheumatism (EULAR) evidence-based recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD). Methods: AIIRD, vaccines and immunomodulating drugs, as well as eight key questions were defined by the multidisciplinary expert committee commissioned by EULAR for developing the recommendations. A SLR was performed using MedLine through October 2009 and including data from meta-analyses, systematic reviews, randomized trials, and observational studies, excluding case series with participants. Articles in English and regarding patients years of age, were eligible. Results: Several vaccine-preventable infections (VPI) occur more often in AIIRD-patients and most vaccines are efficacious in AIIRD-patients, even when treated with immunomodulating agents, except rituximab. There does not appear to be an increase in vaccination-related harms in vaccinated patients with AIIRD in comparison with unvaccinated patients with AIIRD. However, these studies are underpowered and therefore not conclusive. Conclusion: Based on the current evidence from the literature, recommendations for vaccination in patients with AIIRD were made. However, more research is needed in particular regarding incidence of VPI, harms of vaccination and the influence of (new and established) immunomodulating agents on vaccination efficacy. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码：341 / 352
页数：12
相关论文
共 161 条
[1]  
Abe T, 1971, Acta Rheumatol Scand, V17, P35
[2]  
Abu-Shakra M, 2002, J RHEUMATOL, V29, P2555
[3]   Prevalence and clinical characteristics of tuberculosis in rheumatoid arthritis patients [J].
Allali, F ;
Rkain, H ;
Faik, A ;
El Hassani, S ;
Hajjaj-Hassouni, N .
CLINICAL RHEUMATOLOGY, 2005, 24 (06) :656-657
[4]  
[Anonymous], ANN RHEUM DIS S2
[5]  
[Anonymous], ANN RHEUM DIS S3
[6]  
ANTONELLI MAS, 1991, AM J MED, V90, P295, DOI 10.1016/0002-9343(91)80008-A
[7]   Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden [J].
Askling, J ;
Fored, CM ;
Brandt, L ;
Baecklund, E ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Romanus, V ;
Klareskog, L ;
Feltelius, N .
ARTHRITIS AND RHEUMATISM, 2005, 52 (07) :1986-1992
[8]  
Balakrishnan C, 1998, J Assoc Physicians India, V46, P682
[9]  
Baronnet L, 2008, ANN RHEUM DIS S, V67, P544
[10]  
Battafarano DF, 1998, ARTHRITIS RHEUM, V41, P1828, DOI 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.3.CO
12345678910